IL6 and COVID-19: In particular, increased levels of inflammatory markers, such as C-reactive protein and d-dimer, and increased levels of inflammatory cytokines, including interleukin (IL)-6, IL-8, and tumor necrosis factor (TNF)-α, are associated with excess inflammation, which increases the risk of mortality in patients with COVID-19 [3,4,5].